2-Phenylacetamide Isolated from the Seeds of Lepidium apetalum and Its Estrogen-Like Effects In Vitro and In Vivo
- PMID: 30205508
- PMCID: PMC6225176
- DOI: 10.3390/molecules23092293
2-Phenylacetamide Isolated from the Seeds of Lepidium apetalum and Its Estrogen-Like Effects In Vitro and In Vivo
Erratum in
-
Correction: Zeng et al. 2-Phenylacetamide Isolated from the Seeds of Lepidium apetalum and Its Estrogen-Like Effects In Vitro and In Vivo. Molecules 2018, 23, 2293.Molecules. 2025 Nov 10;30(22):4347. doi: 10.3390/molecules30224347. Molecules. 2025. PMID: 41302547 Free PMC article.
Abstract
The aim of this study was to investigate the estrogen-like effects of 2-phenylacetamide (PA), which is the main compound isolated from the seeds of Lepidium apetalum Willd (LA). Results showed that LA and PA could promote the proliferation of MCF-7 cells. The mouse uterine weight test showed that, LA and PA could increase the uterus index of immature female mice, and the levels of luteinizing hormone (LH) and estrogen (E2). LA could increase the expression of ERα and ERβ, while PA could increase the expression of ERα, ERβ and GPR30 in the uterus and MCF-7 cells. In addition, co-incubation of the estrogen receptor blocker with LA or PA abolished the inductive effect of the proliferation. PA has estrogenic activities and was the material basis of LA that played the estrogenic effect. LA and PA might be used for the treatment of perimenopause syndrome in a novel application.
Keywords: 2-phenylacetamide; ERα; ERβ; GPR30; Lepidium apetalum Willd; estrogen-like effects.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
References
-
- Kobayashi N., Fujino T., Shirogane T., Furuta I., Kobamatsu Y., Yaegashi M., Sakuragi N., Fujimoto S. Estrogen receptor alpha polymorphism as a genetic marker for bone loss, vertebral fractures and susceptibility to estrogen. Maturitas. 2002;41:193–201. doi: 10.1016/S0378-5122(01)00287-0. - DOI - PubMed
-
- Zhou K., Sun P., Zhang Y., You X., Li P., Wang T. Estrogen stimulated migration and invasion of estrogen receptor-negative breast cancer cells involves an ezrin-dependent crosstalk between G protein-coupled receptor 30 and estrogen receptor beta signaling. Steroids. 2016;111:113–120. doi: 10.1016/j.steroids.2016.01.021. - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
